NCT00626496招募中不适用
Genetic Epidemiology of Lymphoproliferative Disorders
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Mayo Clinic
- 入组人数
- 3,000
- 试验地点
- 1
- 主要终点
- Risk of blood or lymphoma
研究概览
简要总结
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.
研究设计
- 研究类型
- Observational
- 观察模型
- Family Based
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 100 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Risk of blood or lymphoma
时间窗: Ongoing
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
进行中(未招募)
不适用
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic CancerWaldenstrom MacroglobulinemiaHodgkin DiseaseNonHodgkin LymphomaMixed Lymphoproliferative DiseaseChronic Lymphocytic LeukemiaNCT00039676National Cancer Institute (NCI)1,836
终止
不适用
Characterization of the Pathogenesis of Primary and Secondary Lymphatic DisordersLymphangiomatosisLymphedemaLymphangiectasiaPulmonary LymphangiectasiaNCT02156115National Heart, Lung, and Blood Institute (NHLBI)14
已完成
不适用
Physical Impairments Related to Myeloid and Lymphoid MalignanciesStem Cell TransplantationNCT03699358Gazi University57
Enrolling By Invitation
不适用
Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow TransplantationStem Cell TransplantationNCT06134297Federal University of Health Science of Porto Alegre93
Enrolling By Invitation
不适用
Pathogenesis of Hematologic MalignanciesLymphoproliferative DisordersMyeloproliferative DisordersMyelodysplastic SyndromesAcute LeukemiaNCT01728402OHSU Knight Cancer Institute5,000
